Correlation Between IMAC Holdings and Rigel Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both IMAC Holdings and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IMAC Holdings and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between IMAC Holdings and Rigel Pharmaceuticals, you can compare the effects of market volatilities on IMAC Holdings and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IMAC Holdings with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of IMAC Holdings and Rigel Pharmaceuticals.
Diversification Opportunities for IMAC Holdings and Rigel Pharmaceuticals
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between IMAC and Rigel is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding IMAC Holdings and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and IMAC Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on IMAC Holdings are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of IMAC Holdings i.e., IMAC Holdings and Rigel Pharmaceuticals go up and down completely randomly.
Pair Corralation between IMAC Holdings and Rigel Pharmaceuticals
Given the investment horizon of 90 days IMAC Holdings is expected to under-perform the Rigel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, IMAC Holdings is 2.74 times less risky than Rigel Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest 1,363 in Rigel Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 1,398 from holding Rigel Pharmaceuticals or generate 102.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
IMAC Holdings vs. Rigel Pharmaceuticals
Performance |
| Timeline |
| IMAC Holdings |
| Rigel Pharmaceuticals |
IMAC Holdings and Rigel Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with IMAC Holdings and Rigel Pharmaceuticals
The main advantage of trading using opposite IMAC Holdings and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IMAC Holdings position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.| IMAC Holdings vs. Oncology Institute | IMAC Holdings vs. Aveanna Healthcare Holdings | IMAC Holdings vs. P3 Health Partners | IMAC Holdings vs. Novo Integrated Sciences |
| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |